This page contains Key Points documents and videos created by DPM faculty for the Clinical Epidemiology and Population Health longitudinal curriculum at Harvard Medical School. These documents and videos are included in preparatory materials for the course, and we build on these concepts in lectures and small group sessions.
A biweekly overview of recent studies published by Institute investigators and their collaborators spans a wide variety of topics, including:
HPI researchers focus on the impact of health policy and insurance design for children as well as adults. Using large claims databases, surveys, and qualitative methods, Dr. Alison Galbraith leads work that has examined the impact of enrollment in high-deductible plans on health care access and affordability for children and families, particularly for those with chronic conditions such as asthma.
Two of the most serious concerns that have historically dominated the health care workforce policy debates in the US are the persistent workforce shortage and the unequal workforce distribution. Using large national data files, Dr.
Only 10% of Americans who need behavioral health care in a given year receive the treatment. Lack of health insurance coverage and discriminatory restrictions on behavioral health benefits pose major financial barriers to treatment.
Affordable, appropriately used, effective medicines are key to quality health care and sustainable health systems everywhere. HPI (formerly the Drug Policy Research Group) has established a national and global reputation for pharmaceutical policy research, including investigating the impacts of policy changes on use of medicines, affordability, and clinical outcomes.
Cancer is a major cause of serious illness, premature deaths, financial toxicity for individuals, and enormous health system spending, in the United States and across the world. Together with HPI fellows, HPI researchers Drs.
Insurance coverage of health care expenses determines access to care, quality of care, and spending on care. Insurance policies change rapidly in response to changing need for care and technologies and costs of care. HPI has long had a major focus on studying impacts of private and public insurance policies on how and by whom health services are used, and on their costs and clinical consequences. In current work, Drs.
It has been a productive year for Institute faculty, nearly 300 publications, many of those as first- or senior-author. Our clinician-researchers on the front lines of the COVID-19 pandemic kept pace, producing high-impact work on the evolving novel coronavirus and its effect on hospitals and healthcare workers. All investigators faced year two of the pandemic head-on.
A biweekly overview of recent studies published by Institute investigators and their collaborators spans a wide variety of topics, including:
The FDA Sentinel System; using epigenetics to measure the effects of breastfeeding; the pharmacogenetics of bronchodilator response; ventilator-associated pneumonia in COVID-19 patients; gestational diabetes risk factors; biologically actionable insights into inhaled corticosteroid response in asthma patients